Aria R Henderson1, Isabelle S Ilan2, Esak Lee1. 1. Nancy E. and Peter C. Meinig School of Biomedical Engineering, Cornell University, Ithaca, New York, USA. 2. College of Human Ecology, Cornell University, Ithaca, New York, USA.
Abstract
OBJECTIVE: Lymphatic vessels (LVs) maintain fluid homeostasis by draining interstitial fluid. A failure in lymphatic drainage triggers lymphatic diseases such as lymphedema. Since lymphatic drainage is regulated by lymphatic barrier function, developing experimental models that assess lymphatic barrier function is critical for better understanding of lymphatic physiology and disease. METHODS: We built a lymphatic vessel-on-chip (LV-on-chip) by fabricating a microfluidic device that includes a hollow microchannel embedded in three-dimensional (3D) hydrogel. Employing luminal flow in the microchannel, human lymphatic endothelial cells (LECs) seeded in the microchannel formed an engineered LV exhibiting 3D conduit structure. RESULTS: Lymphatic endothelial cells formed relatively permeable junctions in 3D collagen 1. However, adding fibronectin to the collagen 1 apparently tightened LEC junctions. We tested lymphatic barrier function by introducing dextran into LV lumens. While LECs in collagen 1 showed permeable barriers, LECs in fibronectin/collagen 1 showed reduced permeability, which was reversed by integrin α5 inhibition. Mechanistically, LECs expressed inactivated integrin α5 in collagen 1. However, integrin α5 is activated in fibronectin and enhances barrier function. Integrin α5 activation itself also tightened LEC junctions in the absence of fibronectin. CONCLUSIONS: Lymphatic vessel-on-chip reveals integrin α5 as a regulator of lymphatic barrier function and provides a platform for studying lymphatic barrier function in various conditions.
OBJECTIVE: Lymphatic vessels (LVs) maintain fluid homeostasis by draining interstitial fluid. A failure in lymphatic drainage triggers lymphatic diseases such as lymphedema. Since lymphatic drainage is regulated by lymphatic barrier function, developing experimental models that assess lymphatic barrier function is critical for better understanding of lymphatic physiology and disease. METHODS: We built a lymphatic vessel-on-chip (LV-on-chip) by fabricating a microfluidic device that includes a hollow microchannel embedded in three-dimensional (3D) hydrogel. Employing luminal flow in the microchannel, human lymphatic endothelial cells (LECs) seeded in the microchannel formed an engineered LV exhibiting 3D conduit structure. RESULTS: Lymphatic endothelial cells formed relatively permeable junctions in 3D collagen 1. However, adding fibronectin to the collagen 1 apparently tightened LEC junctions. We tested lymphatic barrier function by introducing dextran into LV lumens. While LECs in collagen 1 showed permeable barriers, LECs in fibronectin/collagen 1 showed reduced permeability, which was reversed by integrin α5 inhibition. Mechanistically, LECs expressed inactivated integrin α5 in collagen 1. However, integrin α5 is activated in fibronectin and enhances barrier function. Integrin α5 activation itself also tightened LEC junctions in the absence of fibronectin. CONCLUSIONS: Lymphatic vessel-on-chip reveals integrin α5 as a regulator of lymphatic barrier function and provides a platform for studying lymphatic barrier function in various conditions.
Authors: Christopher P Loo; Nicholas A Nelson; Ryan S Lane; Jamie L Booth; Sofia C Loprinzi Hardin; Archana Thomas; Mark K Slifka; Jeffrey C Nolz; Amanda W Lund Journal: Cell Rep Date: 2017-09-26 Impact factor: 9.423
Authors: William J Polacheck; Matthew L Kutys; Jinling Yang; Jeroen Eyckmans; Yinyu Wu; Hema Vasavada; Karen K Hirschi; Christopher S Chen Journal: Nature Date: 2017-11-13 Impact factor: 49.962
Authors: Antoine Louveau; Jasmin Herz; Maria Nordheim Alme; Andrea Francesca Salvador; Michael Q Dong; Kenneth E Viar; S Grace Herod; James Knopp; Joshua C Setliff; Alexander L Lupi; Sandro Da Mesquita; Elizabeth L Frost; Alban Gaultier; Tajie H Harris; Rui Cao; Song Hu; John R Lukens; Igor Smirnov; Christopher C Overall; Guillermo Oliver; Jonathan Kipnis Journal: Nat Neurosci Date: 2018-09-17 Impact factor: 24.884
Authors: Jennifer H Hammel; Jonathan M Zatorski; Sophie R Cook; Rebecca R Pompano; Jennifer M Munson Journal: Adv Drug Deliv Rev Date: 2022-01-11 Impact factor: 15.470
Authors: Arinola O Lampejo; Nien-Wen Hu; Daniela Lucas; Banks M Lomel; Christian M Nguyen; Carmen C Dominguez; Bing Ren; Yong Huang; Walter L Murfee Journal: Front Bioeng Biotechnol Date: 2022-06-20